Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulations
申请人:——
公开号:US20040122044A1
公开(公告)日:2004-06-24
Methods of using pharmaceutical formulations with imidazo[1,2-a]-pyridin-3-yl-amide or -amine compounds as active ingredients to inhibit nitric oxide synthase are disclosed. Treatments of certain conditions using imidazo[1,2-a]-pyridin-3-yl-amide or -amine compounds are also disclosed, as are processes for preparing imidazo[1,2-a]-pyridin-3-yl-amide or -amine compounds.